Eagle Pharmaceuticals Operating Margin 2013-2023 | EGRX
Current and historical operating margin for Eagle Pharmaceuticals (EGRX) over the last 10 years. The current operating profit margin for Eagle Pharmaceuticals as of June 30, 2023 is 0.00%.
| Eagle Pharmaceuticals Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2023-06-30 | $0.26B | $0.04B | 15.50% |
| 2023-03-31 | $0.27B | $0.03B | 11.99% |
| 2022-12-31 | $0.32B | $0.08B | 25.24% |
| 2022-09-30 | $0.30B | $0.08B | 25.84% |
| 2022-06-30 | $0.27B | $0.06B | 21.32% |
| 2022-03-31 | $0.25B | $0.07B | 27.24% |
| 2021-12-31 | $0.17B | $0.00B | 1.75% |
| 2021-09-30 | $0.18B | $0.01B | 3.91% |
| 2021-06-30 | $0.19B | $0.03B | 16.93% |
| 2021-03-31 | $0.18B | $0.03B | 13.66% |
| 2020-12-31 | $0.19B | $0.03B | 17.55% |
| 2020-09-30 | $0.19B | $0.03B | 13.98% |
| 2020-06-30 | $0.18B | $0.01B | 5.08% |
| 2020-03-31 | $0.19B | $0.01B | 7.29% |
| 2019-12-31 | $0.20B | $0.02B | 11.22% |
| 2019-09-30 | $0.20B | $0.04B | 17.16% |
| 2019-06-30 | $0.21B | $0.06B | 25.70% |
| 2019-03-31 | $0.22B | $0.05B | 21.30% |
| 2018-12-31 | $0.21B | $0.04B | 16.90% |
| 2018-09-30 | $0.20B | $0.03B | 14.71% |
| 2018-06-30 | $0.22B | $0.04B | 17.13% |
| 2018-03-31 | $0.21B | $0.04B | 20.77% |
| 2017-12-31 | $0.24B | $0.07B | 31.22% |
| 2017-09-30 | $0.27B | $0.09B | 33.95% |
| 2017-06-30 | $0.25B | $0.08B | 32.11% |
| 2017-03-31 | $0.24B | $0.09B | 36.71% |
| 2016-12-31 | $0.19B | $0.05B | 27.89% |
| 2016-09-30 | $0.13B | $0.03B | 20.47% |
| 2016-06-30 | $0.10B | $0.00B | 4.21% |
| 2016-03-31 | $0.06B | $-0.02B | -30.00% |
| 2015-12-31 | $0.07B | $0.00B | 4.55% |
| 2015-09-30 | $0.05B | $-0.01B | -9.26% |
| 2015-06-30 | $0.05B | $-0.00B | -7.84% |
| 2015-03-31 | $0.05B | $0.00B | 1.96% |
| 2014-12-31 | $0.02B | $-0.02B | -115.00% |
| 2014-09-30 | $0.02B | $-0.02B | -100.00% |
| 2014-06-30 | $0.02B | $-0.01B | -23.81% |
| 2014-03-31 | $0.02B | $-0.00B | -5.00% |
| 2013-12-31 | $0.02B | $-0.00B | -5.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.010B | $0.317B |
| Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.653B | 25.08 |
| Stryker (SYK) | United States | $142.804B | 32.18 |
| Boston Scientific (BSX) | United States | $132.807B | 38.18 |
| EssilorLuxottica (ESLOY) | France | $110.936B | 0.00 |
| Medtronic (MDT) | Ireland | $105.763B | 15.71 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.076B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.052B | 19.22 |
| ResMed (RMD) | United States | $35.014B | 28.77 |
| Terumo (TRUMY) | Japan | $29.635B | 41.85 |
| Koninklijke Philips (PHG) | Netherlands | $24.241B | 18.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.249B | 13.53 |
| Insulet (PODD) | United States | $18.893B | 75.23 |
| Baxter (BAX) | United States | $15.481B | 10.07 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.161B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.045B | 40.41 |
| Bio-Rad Laboratories (BIO) | United States | $9.415B | 32.00 |
| Demant (WILYY) | Denmark | $8.300B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.467B | 15.03 |
| Haemonetics (HAE) | United States | $4.078B | 19.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.066B | 20.22 |
| ICU Medical (ICUI) | United States | $3.958B | 37.68 |
| Perrigo (PRGO) | Ireland | $3.745B | 11.02 |
| Envista Holdings (NVST) | United States | $3.351B | 24.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.928B | 18.78 |
| QuidelOrtho (QDEL) | United States | $2.781B | 17.90 |
| Neogen (NEOG) | United States | $2.633B | 30.37 |
| LeMaitre Vascular (LMAT) | United States | $2.264B | 55.02 |
| Green Thumb Industries (GTBIF) | United States | $1.710B | 29.93 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| InMode (INMD) | Israel | $1.534B | 9.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.432B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 9.18 |
| BioLife Solutions (BLFS) | United States | $1.239B | 0.00 |
| Owens & Minor (OMI) | United States | $1.075B | 8.40 |
| CeriBell (CBLL) | United States | $1.047B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.031B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.918B | 16.19 |
| Evolus (EOLS) | United States | $0.729B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.635B | 28.07 |
| Capricor Therapeutics (CAPR) | United States | $0.603B | 0.00 |
| Surmodics (SRDX) | United States | $0.573B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.488B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Omeros (OMER) | United States | $0.442B | 0.00 |
| Quanterix (QTRX) | United States | $0.410B | 0.00 |
| ZimVie (ZIMV) | United States | $0.379B | 31.93 |
| Biote (BTMD) | United States | $0.346B | 7.58 |
| Viemed Healthcare (VMD) | United States | $0.340B | 32.37 |
| Canopy Growth (CGC) | Canada | $0.339B | 0.00 |
| Valneva SE (VALN) | France | $0.319B | 0.00 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Zynex (ZYXI) | United States | $0.259B | 54.27 |
| High Tide (HITI) | Canada | $0.257B | 106.33 |
| Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.213B | 14.73 |
| MacroGenics (MGNX) | United States | $0.201B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.187B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.176B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.173B | 2.43 |
| Brainsway (BWAY) | Israel | $0.157B | 94.20 |
| FitLife Brands (FTLF) | United States | $0.156B | 19.65 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.119B | 0.00 |
| Veru (VERU) | United States | $0.106B | 0.00 |
| Exagen (XGN) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 11.09 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.055B | 0.00 |
| Safety Shot (SHOT) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.93 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |